메뉴 건너뛰기




Volumn 32, Issue 10, 2014, Pages 2054-2063

Combinations of olmesartan and a calciumchannel blocker or a diuretic inelderly hypertensive patients: A randomized, controlled trial

(815)  Ogihara, Toshio a   Saruta, Takao b   Rakugi, Hiromi c   Saito, Ikuo b   Shimamoto, Kazuaki d   Matsuoka, Hiroaki e   Shimada, Kazuyuki f   Ito, Sadayoshi g   Horiuchi, Masatsugu h   Imaizumi, Tsutomu i   Takishita, Shuichi j   Higaki, Jitsuo h   Katayama, Shigehiro k   Kimura, Genjiroh l   Umemura, Satoshi m   Ura, Nobuyuki n   Hayashi, Koichi b   Odawara, Masato o   Tanahashi, Norio k   Ishimitsu, Toshihiko e   more..


Author keywords

Blood pressure; Calcium channel blockers; Diuretics; Hypertension; Olmesartan; Randomized controlled trial

Indexed keywords

AMLODIPINE; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; OLMESARTAN; TRICHLORMETHIAZIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

EID: 84920533602     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000281     Document Type: Article
Times cited : (46)

References (23)
  • 1
    • 0029886630 scopus 로고    scopus 로고
    • Blood pressure as a cardiovascular risk factor: Prevention and treatment
    • Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275:1571-1576.
    • (1996) JAMA , vol.275 , pp. 1571-1576
    • Kannel, W.B.1
  • 2
    • 0038203004 scopus 로고    scopus 로고
    • Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003
    • Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21:1055-1076.
    • (2003) J Hypertens , vol.21 , pp. 1055-1076
    • Staessen, J.A.1    Wang, J.G.2    Thijs, L.3
  • 3
    • 0033922808 scopus 로고    scopus 로고
    • Therapeutic approaches to achieve desired blood pressure goals: Focus on calcium channel blockers
    • Koshy S, Bakris GL. Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers. Cardiovasc Drugs Ther 2000; 14:295-301.
    • (2000) Cardiovasc Drugs Ther , vol.14 , pp. 295-301
    • Koshy, S.1    Bakris, G.L.2
  • 4
    • 84893549987 scopus 로고    scopus 로고
    • 2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC8)
    • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC8). JAMA 2014; 311:507-520.
    • (2014) JAMA , vol.311 , pp. 507-520
    • James, P.A.1    Oparil, S.2    Carter, B.L.3    Cushman, W.C.4    Dennison-Himmelfarb, C.5    Handler, J.6
  • 5
    • 84880015206 scopus 로고    scopus 로고
    • 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G, Fagard R, Narkiewicz K, Redon J, Zancketti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
    • (2013) J Hypertens , vol.31 , pp. 1281-1357
    • Mancia, G.1    Fagard, R.2    Narkiewicz, K.3    Redon, J.4    Zancketti, A.5    Bohm, M.6
  • 6
    • 77952304034 scopus 로고    scopus 로고
    • The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009)
    • Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
    • (2009) Hypertens Res , vol.32 , pp. 3-107
    • Ogihara, T.1    Kikuchi, K.2    Matsuoka, H.3    Fujita, T.4    Higaki, J.5    Horiuchi, M.6
  • 7
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • ACCOMPLISH trial investigators
    • Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
    • (2008) N Engl J Med , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3    Dahlöf, B.4    Pitt, B.5    Shi, V.6
  • 8
    • 79960591166 scopus 로고    scopus 로고
    • Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: A randomized controlled trial
    • Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, et al. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. J Hypertens 2011; 29:1649-1659.
    • (2011) J Hypertens , vol.29 , pp. 1649-1659
    • Matsuzaki, M.1    Ogihara, T.2    Umemoto, S.3    Rakugi, H.4    Matsuoka, H.5    Shimada, K.6
  • 9
    • 82455162519 scopus 로고    scopus 로고
    • Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: A multicentre, randomised, placebo-controlled study
    • ORIENT study investigators
    • Imai E, Chan JC, Ito S, Kobayashi F, Haneda M, Makino H, ORIENT Study Investigators. Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia 2011; 54:2978-2986.
    • (2011) Diabetologia , vol.54 , pp. 2978-2986
    • Imai, E.1    Chan, J.C.2    Ito, S.3    Kobayashi, F.4    Haneda, M.5    Makino, H.6
  • 10
    • 79952373965 scopus 로고    scopus 로고
    • Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
    • ROADMAP trial investigators
    • Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, et al., ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011; 364:907-917.
    • (2011) N Engl J Med , vol.364 , pp. 907-917
    • Haller, H.1    Ito, S.2    Izzo, J.L.3    Januszewicz, A.4    Katayama, S.5    Menne, J.6
  • 11
    • 84866500279 scopus 로고    scopus 로고
    • Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients
    • Olmesartan and calcium antagonists randomized (OSCAR) study group
    • Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K, OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med 2012; 125:981-990.
    • (2012) Am J Med , vol.125 , pp. 981-990
    • Ogawa, H.1    Kim-Mitsuyama, S.2    Matsui, K.3    Jinnouchi, T.4    Jinnouchi, H.5    Arakawa, K.6
  • 12
    • 84870798859 scopus 로고    scopus 로고
    • Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: The OMEGA study
    • OMEGA study group
    • Teramoto T, Kawamori R, Miyazaki S, Teramukai S, Shirayama M, Hiramatsu K, Kobayashi F, OMEGA Study Group. Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study. Hypertens Res 2012; 35:1136-1144.
    • (2012) Hypertens Res , vol.35 , pp. 1136-1144
    • Teramoto, T.1    Kawamori, R.2    Miyazaki, S.3    Teramukai, S.4    Shirayama, M.5    Hiramatsu, K.6    Kobayashi, F.7
  • 13
    • 70349668492 scopus 로고    scopus 로고
    • Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients
    • Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54:716-723.
    • (2009) Hypertension , vol.54 , pp. 716-723
    • Matsui, Y.1    Eguchi, K.2    O'rourke, M.F.3    Ishikawa, J.4    Miyashita, H.5    Shimada, K.6    Kario, K.7
  • 14
    • 68249147700 scopus 로고    scopus 로고
    • COLM study investigators, Rationale, study design and implementation of the COLM study: The Combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
    • Ogihara T, Saruta T, Rakugi H, Shimamoto K, Ito S, Matsuoka H, et al., COLM Study Investigators. Rationale, study design and implementation of the COLM study: the Combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients. Hypertens Res 2009; 32:163-167.
    • (2009) Hypertens Res , vol.32 , pp. 163-167
    • Ogihara, T.1    Saruta, T.2    Rakugi, H.3    Shimamoto, K.4    Ito, S.5    Matsuoka, H.6
  • 15
    • 33748918856 scopus 로고    scopus 로고
    • The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004)
    • Japanese Society of Hypertension
    • Japanese Society of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29:S1-S105.
    • (2006) Hypertens Res , vol.29 , pp. S1-S105
  • 16
    • 33846085210 scopus 로고    scopus 로고
    • Current usage of diuretics among hypertensive patients in Japan: The Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) Study
    • J-home study group
    • Murai K, Obara T, Ohkubo T, Metoki H, Oikawa T, Inoue R, et al., J-Home Study Group. Current usage of diuretics among hypertensive patients in Japan: the Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) Study. Hypertens Res 2006; 29:857-863.
    • (2006) Hypertens Res , vol.29 , pp. 857-863
    • Murai, K.1    Obara, T.2    Ohkubo, T.3    Metoki, H.4    Oikawa, T.5    Inoue, R.6
  • 17
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlöf, B.1    Devereux, R.B.2    Kjeldsen, S.E.3    Julius, S.4    Beevers, G.5    De Faire, U.6
  • 18
    • 24644443331 scopus 로고    scopus 로고
    • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial
    • ASCOT Investigators
    • Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, et al., ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906.
    • (2005) Lancet , vol.366 , pp. 895-906
    • Wedel, H.1    Beevers, D.G.2    Caulfield, M.3    Collins, R.4    Kjeldsen, S.E.5    Kristinsson, A.6
  • 19
    • 0242654867 scopus 로고    scopus 로고
    • Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials
    • Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
    • (2003) Lancet , vol.362 , pp. 1527-1535
    • Turnbull, F.1
  • 20
    • 34147116836 scopus 로고    scopus 로고
    • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Blood Pressure Lowering Treatment Trialists' CollaborationTurnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25:951-958.
    • (2007) J Hypertens , vol.25 , pp. 951-958
    • Turnbull, F.1    Neal, B.2    Pfeffer, M.3    Kostis, J.4    Algert, C.5    Woodward, M.6
  • 21
    • 44349101152 scopus 로고    scopus 로고
    • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomized trials
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Blood Pressure Lowering Treatment Trialists' CollaborationTurnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ 2008; 336:1121-1123.
    • (2008) BMJ , vol.336 , pp. 1121-1123
    • Turnbull, F.1    Neal, B.2    Ninomiya, T.3    Algert, C.4    Arima, H.5    Barzi, F.6
  • 22
    • 29144506962 scopus 로고    scopus 로고
    • Hypertension: A review and rationale of treatment
    • Copley JB, Rosario R. Hypertension: a review and rationale of treatment. Dis Mon 2005; 51:548-614.
    • (2005) Dis Mon , vol.51 , pp. 548-614
    • Copley, J.B.1    Rosario, R.2
  • 23
    • 77952106918 scopus 로고    scopus 로고
    • Combination therapy in hypertension
    • American society of hypertension writing group
    • Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of Hypertension Writing Group. Combination therapy in hypertension. J Am Soc Hypertens 2010; 4:42-50.
    • (2010) J Am Soc Hypertens , vol.4 , pp. 42-50
    • Gradman, A.H.1    Basile, J.N.2    Carter, B.L.3    Bakris, G.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.